PZ Cormay SA

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PLCMRAY00029
PLN
0.37
0.01 (2.5%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About PZ Cormay SA stock-summary
stock-summary
PZ Cormay SA
Pharmaceuticals & Biotechnology
PZ Cormay SA is a Polish-based producer and wholesaler of diagnostic reagents and a distributor of the laboratory equipment. The Company is engaged in the design, manufacture and distribution of a range of products for clinical chemistry, hematology, electrophoresis, parasitology, cytology, coagulation and specific protein recognition. It offers drugs, biochemical rapid tests and devices such as vacuettes and tubes. PZ Cormay SA provides also biochemical analyzers: ACCENT-300, ACCENT-200, PRESTIGE 24i and LIVIA; hematological analyzers: MYTHIC 18, among others, and urinalysis apparatus: IChem 100. On September 1, 2014, Orphee SA acquired 100% stake in TT Management Sp z o o to enable execution of the restructuring plan of Cormay group which aims at transferring production and distribution activity of Cormay group to Orphee SA.
Company Coordinates stock-summary
Company Details
Ul. Wiosenna 22 , LOMIANKI None : 05-092
stock-summary
Tel: 48 22 751791048 692 823744
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Konrad Lapinski
Chairman of the Supervisory Board
Mr. Piotr Augustyniak
Independent Member of the Supervisory Board
Mr. Tomasz Markowski
Member of the Supervisory Board
Mr. Andrzej Trznadel
Member of the Supervisory Board
Dr. Tadeusz Wesolowski
Member of the Supervisory Board
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
23 Million
(Quarterly Results - Mar 2025)
Net Profit:
1 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

PLN 33 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.03

stock-summary
Return on Equity

-4.69%

stock-summary
Price to Book

0.69